DNUT:NASDAQKrispy Kreme, Inc. Analysis
Data as of 2026-07-16 - not real-time
$3.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Krispy Kreme’s price is trading just above a key support level, with the 20‑day SMA (≈$3.50) and 50‑day SMA (≈$3.51) converging below the current market price of $3.41, indicating limited upside momentum. The RSI sits in the mid‑40s, suggesting neutral to slightly bearish momentum, while the MACD histogram remains negative, reinforcing a bearish bias. Volatility is elevated at roughly 65% over the past 30 days and beta is below 1, meaning the stock moves less than the broader market but still experiences sharp price swings. Recent news of an 8.6% intraday rally tied to lower oil prices provided a short‑term boost, yet the underlying fundamentals remain weak. Operating margins are negative, the company carries a debt‑to‑equity ratio above 200%, and ROE is deeply in the red, making earnings sustainability a concern. Despite a dividend yield near 3.5%, the payout is built on negative earnings, raising doubts about its durability. The forward PE of about 64 and a price‑to‑book under 1 hint at a mixed valuation picture, while the upside/downside estimate of +27%/‑17% reflects modest upside potential if the turnaround succeeds. Overall, the stock faces a bearish technical backdrop, high valuation multiples relative to earnings, and a fragile balance sheet, with only limited catalysts on the horizon.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and RSI near neutral
- Price hovering just above support with limited upside
- Negative earnings and high debt amplify downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential turnaround from capital‑light initiatives
- Dividend yield attractive if earnings improve
- Volatility and balance‑sheet constraints limit confidence
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Price‑to‑book below 1 suggests hidden value
- International footprint offers growth avenues
- If the company can reverse negative margins, upside to target median price becomes plausible
Key Metrics & Analysis
Financial Health
Revenue Growth-2.20%
Profit Margin-33.36%
P/E Ratio63.8
ROE-58.15%
ROA-1.16%
Debt/Equity201.77
P/B Ratio0.9
Op. Cash Flow$74.9M
Free Cash Flow$22.4M
Technical Analysis
TrendBearish
RSI46.2
Support$3.26
Resistance$3.89
MA 20$3.50
MA 50$3.51
MA 200$3.65
MACDBearish
VolumeStable
Fear & Greed Index91.55
Valuation
Target Price$4.35
Upside/Downside27.57%
GradeOvervalued
TypeValue
Dividend Yield3.47%
Risk Assessment
Beta0.86
Volatility64.77%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.